Growth Metrics

Veon (VEON) Operating Expenses (2016 - 2025)

Veon has reported Operating Expenses over the past 15 years, most recently at -$464.0 million for Q2 2025.

  • For Q2 2025, Operating Expenses fell 4.04% year-over-year to -$464.0 million; the TTM value through Dec 2025 reached -$1.8 billion, down 34.91%, while the annual FY2025 figure was $2.5 billion, 5.71% up from the prior year.
  • Operating Expenses was -$464.0 million for Q2 2025 at Veon, up from -$883.0 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $3.4 billion in Q4 2021 and bottomed at -$883.0 million in Q4 2024.
  • The 5-year median for Operating Expenses is -$545.0 million (2021), against an average of -$186.1 million.
  • Year-over-year, Operating Expenses skyrocketed 349.78% in 2021 and then tumbled 123.01% in 2022.
  • Over 5 years, Operating Expenses stood at $3.4 billion in 2021, then tumbled by 123.01% to -$777.0 million in 2022, then soared by 49.68% to -$391.0 million in 2023, then plummeted by 125.83% to -$883.0 million in 2024, then surged by 47.45% to -$464.0 million in 2025.
  • The last three reported values for Operating Expenses were -$464.0 million (Q2 2025), -$883.0 million (Q4 2024), and -$446.0 million (Q2 2024) per Business Quant data.